Identification of Shared Neoantigens in BRCA1-Related Breast Cancer

Personalized neoantigen-based cancer vaccines have been shown to be safe and immunogenic in cancer patients; however, the manufacturing process can be costly and bring about delays in treatment. Using off-the-shelf cancer vaccines targeting shared neoantigens may circumvent these problems. Unique mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruangapirom, Lucksica, Sutivijit, Nannapat, Teerapakpinyo, Chinachote, Mutirangura, Apiwat, Doungkamchan, Chatchanan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609887/
https://www.ncbi.nlm.nih.gov/pubmed/36298462
http://dx.doi.org/10.3390/vaccines10101597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609887/
https://www.ncbi.nlm.nih.gov/pubmed/36298462
http://dx.doi.org/10.3390/vaccines10101597

Ejemplares similares